Acute gouty arthritis during pyrazinamide treatment: a case report

Acute gouty arthritis during pyrazinamide treatment: a case report

Gout is a disease caused by an inflammatory response to an aggregation of monosodium urate crystals that develop secondary to hyperuricemia. Throughout its natural history it has four stages: asymptomatic hyperuricemia, acute gouty arthritis, intercritical gout, and chronic tophaceous gout. In this...

Full description

Saved in:
Bibliographic Details
Published in:Modern rheumatology Vol. 14; no. 4; p. 306
Main Authors: Tosun, Aliye Kapukiran, Nadide Torlak Koca, Gülçin Kaymak Karatas
Format: Journal Article
Language:English
Published: Tokyo Informa Healthcare 01-09-2004
Subjects:
Arthritis
Drug therapy
Medical treatment
Rheumatism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gout is a disease caused by an inflammatory response to an aggregation of monosodium urate crystals that develop secondary to hyperuricemia. Throughout its natural history it has four stages: asymptomatic hyperuricemia, acute gouty arthritis, intercritical gout, and chronic tophaceous gout. In this article, we report the case of a patient who had asymptomatic hyperuricemia secondary to pyrazinamide, which was prescribed for pulmonary tuberculosis, and had developed an acute gouty arthritis immediately after the Feast of Sacrifice due to a dietary excess of purine. [PUBLICATION ABSTRACT]
ISSN:1439-7595
1439-7609
DOI:10.1007/s10165-004-0314-5